Chile vs New Zealand: New cases tested for RR-/MDR-TB
Chile
100.0%
in 2024
New Zealand
100.0%
in 2014
Chile rank
1st
New Zealand rank
1st
New cases tested for RR-/MDR-TB over time
- Chile
- New Zealand
How they compare
Chile currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2005 it was New Zealand ahead.
Chile ranks 1st and New Zealand ranks 1st of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.1% | 100.0% | 95.9% | New Zealand |
| 2010s | 21.3% | 80.5% | 59.2% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Chile or New Zealand?
- Chile, at 100.0% against 100.0% in New Zealand as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Chile and New Zealand?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and New Zealand?
- 10 years are reported by both, from 2005 to 2014.
- How do Chile and New Zealand rank globally for new cases tested for rr-/mdr-tb?
- Chile ranks 1st and New Zealand ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.